Terms: = Sarcomas AND RNF43, DKFZp781H02126, 54894, Q68DV7, URCC, RNF124, MGC125630, FLJ20315, DKFZp781H0392
3 results:
1. Pan-cancer analysis identifies rnf43 as a prognostic, therapeutic and immunological biomarker.
Xu Y; Lin Z; Ji Y; Zhang C; Tang X; Li C; Liu T
Eur J Med Res; 2023 Oct; 28(1):438. PubMed ID: 37848933
[TBL] [Abstract] [Full Text] [Related]
2. Identification of methyltransferase modification genes associated with prognosis and immune features of pancreatic adenocarcinoma.
Wang W; Zhang D; Chang D; Li Y; Ren L
Mol Cell Probes; 2023 Feb; 67():101897. PubMed ID: 36740149
[TBL] [Abstract] [Full Text] [Related]
3. RSPO2 inhibition of rnf43 and ZNRF3 governs limb development independently of LGR4/5/6.
Szenker-Ravi E; Altunoglu U; Leushacke M; Bosso-Lefèvre C; Khatoo M; Thi Tran H; Naert T; Noelanders R; Hajamohideen A; Beneteau C; de Sousa SB; Karaman B; Latypova X; Başaran S; Yücel EB; Tan TT; Vlaminck L; Nayak SS; Shukla A; Girisha KM; Le Caignec C; Soshnikova N; Uyguner ZO; Vleminckx K; Barker N; Kayserili H; Reversade B
Nature; 2018 May; 557(7706):564-569. PubMed ID: 29769720
[TBL] [Abstract] [Full Text] [Related]
